Flo Health Revenue, Valuation, Funding & Investors
Flo Health is valued at $1.2B as of July 2024, a 4.1x multiple on its last reported $300M revenue.
Last Flo Health valuation
$1.2B
Series C · Jul 2024
Last Flo Health funding round
$201M
Series C · Jul 2024
Flo Health revenue
$300M
Series C · Jul 2024
Key investors in Flo Health
Flint Capital
Elysium Venture Capital
Social Discovery Group
Founders Fund
General Atlantic
Target Global
About Flo Health
Flo Health is a London-based femtech company behind Flo, a mobile app that tracks menstrual cycles, fertility, pregnancy, and menopause. The OB-GYN-informed app provides personalized health insights, cycle predictions, symptom pattern analysis, and real-time health alerts, and operates on a subscription model with nearly 70 million monthly active users and close to five million paid subscribers. Flo Health also runs a pro-social program that offers free premium access to nearly 16 million women in underserved regions across 66 countries.
Founded
2015
HQ
United KingdomWebsite
Status
Privately held
Customer focus
B2C
Revenue model
Subscription
Revenue
$300M (Jul 2024)
Valuation
$1.2B (Jul 2024)
Flo Health Valuation
Flo Health is currently valued at $1.2B, based on its Series C in July 2024.
The $201M round was led by General Atlantic.
Flo Health's valuation has grown 6.1x from $200M at its Series A in October 2018 to $1.2B in July 2024, across 4 priced rounds.
Flo Health valuation by funding round
Revenue multiple| Date | Stage | Valuation | Revenue Multiple |
|---|---|---|---|
| Jul 2024 | Series C | $1.2B | 4.1x |
| Sep 2021 | Series B | $800M | 8.0x |
| May 2019 | Series A | $230M | - |
| Oct 2018 | Series A | $200M | - |
Flo Health Revenue
Flo Health's latest recorded revenue is $300M, as of its Series C in July 2024. At a $1.2B valuation, that implies a 4.1x revenue multiple.
Revenue grew from $100M in September 2021 to $300M in July 2024, while the revenue multiple moved from 8.0x to 4.1x.
Flo Health revenue by funding round
| Date | Revenue * | Valuation | Revenue Multiple | Stage |
|---|---|---|---|---|
| Jul 2024 | $300M | $1.2B | 4.1x | Series C |
| Sep 2021 | $100M | $800M | 8.0x | Series B |
* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.
Flo Health Funding History
Flo Health has raised a total of $276M across 6 funding rounds.
Flo Health's first fundraising round was a $1M seed round in December 2016. The most recent completed round was a $201M Series C in July 2024.
Flo Health funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Jul 2024 | Series C | General Atlantic (lead) | $201M | $1.2B | Flo Health, the world's top-downloaded women's health app, raised more than $200 million in a Series C funding round on July 30, 2024, led by General Atlantic as the sole investor in this minority investment. The round propelled the company's post-money valuation beyond $1 billion, marking it as the first purely digital consumer women's health app to achieve unicorn status. Flo, based in London with global offices, tracks menstrual cycles, fertility, pregnancy, and menopause, serving nearly 70 million monthly active users and close to 5 million paid subscribers as of June 2024. The funding supports Flo's next growth phase, including expansion into perimenopause and menopause segments, enhanced tech-driven health insights, strategic opportunities, and increased R&D headcount in Europe and North America. Flo leverages General Atlantic's expertise in scaling consumer tech, healthcare, and subscription models. Flo positions itself as a leader in the femtech market, projected to reach $60 billion by 2027, addressing gaps in women's health services and normalizing conversations globally, especially in underserved regions via its pro-social program offering free Premium access in 66 countries to nearly 16 million women. Prior funding included a $50 million Series B in 2021, bringing total raised to at least $265 million. |
| Sep 2021 | Series B | Target Global (lead); VNV Global (lead); Aerion Partners | $50M | $800M | Flo Health is a London-based femtech company offering an OB-GYN-recommended mobile app for period and cycle tracking, providing personalized health insights, cycle predictions, symptom pattern analysis, and real-time health alerts to support women throughout their reproductive cycles. The app operates on a subscription-based business model and had built a community of over 200 million users with 1.5 million monthly active users as of August 2021. It was the most downloaded health app in the App Store in 2020 and has introduced employer benefits in the US to support women's workplace health. On September 9, 2021, Flo Health closed a $50 million Series B funding round co-led by VNV Global and Target Global, bringing total capital raised to $65 million and post-money valuation to $800 million. Previous investors include those from earlier rounds totaling $15 million. The funds are earmarked for enhancing app personalization, advancing cycle insights and symptom analytics, expanding the global team in product, engineering, R&D, data science, and medical roles, and fueling overall growth in the preventative women's health space. VNV Global and Target Global, both with portfolios including Babylon Health, Lyft, Delivery Hero, and Bird, highlighted Flo's pioneering role in addressing neglected areas of female preventative care through its medically expert, AI-driven platform. At the time, Flo held a strong market position as a category-defining leader in femtech, ahead of emerging competitors focusing on specific conditions, with impressive user scale positioning it for continued dominance. Flo later achieved unicorn status in a July 2024 Series C round raising $200 million at over $1 billion valuation led by General Atlantic, with reported traction of nearly 70 million monthly active users and five million paid subscribers by then. |
| May 2019 | Series A | Elysium Venture Capital (lead); Zachary Hargreaves; Eugene Nevgen; Social Discovery Group; Nikita Bier; Flint Capital; Founders Fund; Sergey Gonchar | $8M | $230M | Flo Health develops Flo, a mobile application for women's health tracking used in the United States and over 100 countries. In 2019, the company raised $7.5 million in an extension of its Series A round led by Elysium Venture Capital, with participation from Founders Fund, Flint Capital, Haxus, business angels Sergey Gonchar and Evgeny Nevgen, and SDVentures, whose stake was valued at $1.2 million. This brought total funding to $20.5 million and valued the company at $230 million post-money. The round supported rapid development of the Flo app, with expectations of reaching 100 million active unique users soon after. Prior to this, Flo completed a $12 million Series A in October 2018 led by Mangrove Capital Partners at a $200 million valuation. Flo Health continued scaling, achieving an $800 million valuation in a $50 million Series B in 2021 led by Target Global and VNV Global. |
| Oct 2018 | Series A | Mangrove Capital Partners (lead); Social Discovery Group; Flint Capital; Elysium Venture Capital | $12M | $200M | Flo Health is a reproductive and menstrual health app offering solutions for women from menstruation to menopause, including cycle predictions, pregnancy calculators, and AI-based health insights. The app launched in October 2015 and by the 2018 funding round had reached 22 million monthly active users across over 200 countries, with over 4 million women using its pregnancy calculator feature. In October 2018, Flo Health raised $12 million in a Series A round led by Mangrove Capital Partners, with participation from Flint Capital, Elysium Venture Capital, and Social Discovery Group, bringing total Series A funding to $12 million at a $200 million valuation. The funds aimed to scale the app's user base, enhance technological capabilities with neural networks and AI algorithms for better symptom detection and health advice, and build the world’s biggest women’s health community for anonymous discussions. The company reported strong early traction, with 500,000 additional pregnancies tracked monthly via its calculator. Flo positioned itself to empower users with proactive health insights and doctor recommendations. |
| Aug 2017 | Series A | Flint Capital (lead) | $5M | - | Flo Health raised $5 million in its Series A funding round in August 2017, led by Flint Capital. The round aimed to expand the app's features and improve user experience in the women's health tech market. This followed a $1 million seed round in December 2016, also from Flint Capital. The Flo app, launched in October 2015, provides menstrual cycle tracking, ovulation predictions, and pregnancy tracking. By later stages, such as the 2018 Series A completion totaling $12 million led by Mangrove Capital Partners with Flint Capital and Haxus participation, the company reached a $200 million valuation and 22 million monthly active users across 200 countries. Subsequent rounds included $7.5 million in 2019 (valuation $230 million), $50 million Series B in 2021 ($800 million valuation), and $200 million Series C in 2024 (over $1 billion valuation). |
| Dec 2016 | Seed | Flint Capital (lead) | $1M | - | - |
Who has invested in Flo Health?
13 investors have backed Flo Health across its funding rounds, including Flint Capital, Elysium Venture Capital, Social Discovery Group, Founders Fund, General Atlantic and Target Global.
Lead investors include General Atlantic, Target Global, VNV Global, Elysium Venture Capital, Mangrove Capital Partners and 1 other investor.
Flo Health Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
 United States | 4 | Lead | Dec 2016 | |
| New York City, NY | 2 | Participant | Oct 2018 | |
| San Francisco, CA | 2 | Lead | Oct 2018 | |
 Stockholm | 1 | Lead | Sep 2021 | |
![](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 20 20"><rect fill="%23e5e7eb" width="20" height="20" rx="4"/></svg>){kind=small} Zachary Hargreaves | San Francisco, CA | 1 | Participant | May 2019 |
| United States | 1 | Participant | May 2019 | |
| Nikita Bier | San Francisco, CA | 1 | Participant | May 2019 |
 Luxembourg | 1 | Lead | Oct 2018 | |
| New York City, NY | 1 | Lead | Jul 2024 | |
| London | 1 | Lead | Sep 2021 | |
| London | 1 | Participant | Sep 2021 | |
This data is available for Pro users. Sign up to see all 13 Flo Health investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialFlo Health Competitors
Flo Health competitors include listed companies like Wondershare and Ireader, and private ones like HubX, Triller, Super.com and IRL.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
 Izmir | Private | - | - | $1.3B | - | |
| Los Angeles, CA | Private | - | - | $1.3B | - | |
| San Francisco, CA | Private | $200M | - | $1.2B | 6.0x | |
| San Francisco, CA | Private | - | - | $1.2B | - | |
 China | Publicly listed | $229M | ($6M) | $1.4B | 6.4x | |
| China | Publicly listed | $484M | ($16M) | $1.5B | 3.5x |
Flo Health Public Comps
Flo Health is still privately-owned, but its public comps include Wondershare, Ireader, Opera, Yalla Group, Truecaller, Hello Group, VNG Corp., Bumble, Kurashiru and Dear U.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $229M | ($6M) | 6.3x | 6.4x | (231.3x) | (175.1x) | |||
| $484M | ($16M) | 2.7x | 3.5x | (81.1x) | - | |||
| $615M | $141M | 2.4x | 2.1x | 10.5x | 9.2x | |||
| $342M | $128M | - | - | - | - | |||
| $195M | $61M | 3.2x | 3.4x | 10.2x | 11.8x | |||
| $1.5B | $215M | - | - | - | - | |||
| $420M | $23M | 1.4x | - | 25.5x | - | |||
| $966M | ($793M) | 0.8x | 0.9x | (1.0x) | 2.9x | |||
This data is available for Pro users. Sign up to see all Flo Health competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Flo Health
| When was Flo Health founded? | Flo Health was founded in 2015. |
| Where is Flo Health headquartered? | Flo Health is headquartered in United Kingdom. |
| Is Flo Health publicly listed? | No, Flo Health is a private, VC-backed company. |
| What is Flo Health's valuation? | Flo Health was last valued at $1.2B in its Series C in July 2024. |
| How much funding has Flo Health raised? | Flo Health has raised $276M across 6 funding rounds. |
| What was Flo Health's last funding round? | Flo Health's last funding round was a $201M Series C in July 2024, led by General Atlantic. |
| Who are Flo Health's investors? | Flo Health's investors include Flint Capital, Social Discovery Group, Elysium Venture Capital, VNV Global, Zachary Hargreaves, Eugene Nevgen, Nikita Bier, Mangrove Capital Partners, General Atlantic, Target Global and 3 others. |
| What is Flo Health's revenue? | Flo Health's latest recorded revenue is $300M (July 2024). |
| What is Flo Health's revenue multiple? | Flo Health's latest valuation implies a 4.1x revenue multiple ($1.2B valuation on $300M of revenue). |
| Which companies are comparable to Flo Health? | Companies comparable to Flo Health include HubX, Triller, Super.com, IRL, Wondershare and Ireader. |
See companies similar to Flo Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.